Computational design of novel nanobodies targeting the receptor binding domain of variants of concern of SARS-CoV-2
Description
The COVID-19 pandemic has created an urgent need for effective therapeutic and diagnostic strategies to manage the disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, the emergence of numerous variants of
